Reduction and Elimination of Encephalitis in an Experimental Glioma Therapy Model with Attenuated Herpes Simplex Mutants that Retain Susceptibility to Acyclovir-Reference-Cited by-同舟云学术

Reduction and Elimination of Encephalitis in an Experimental Glioma Therapy Model with Attenuated Herpes Simplex Mutants that Retain Susceptibility to Acyclovir

Published:1993-04 Issue:4 Volume:32 Page:597-603
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Markert James M.,Malick Amy,Coen Donald M.,Martuza Robert L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Reference35 articles.

1. Virus augmentation of the antigenicity of tumor cell extracts;Adv Cancer Res,1979

2. Vitiligo in a case of vaccinia virus-treated melanoma;Cancer,1964

3. A phase II study on the postsurgical management of stage II malignant melanoma with a Newcastle disease virus oncolysate;Cancer,1983

4. Mapping of herpes simplex virus-1 neurovirulence to gamma-1 34.5, a gene nonessential for growth in culture;Science,1990

5. The gamma-1 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells;Proc Natl Acad Sci USA,1992

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of Oncolytic Virus;Journal of Biomedical Nanotechnology;2024-10-01

2. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies;Life Sciences;2024-07

3. Viral vector‐based cancer treatment and current clinical applications;MedComm – Oncology;2023-10-29

4. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical;Clinical and Translational Oncology;2022-05-25

5. Oncolytic viruses in immunotherapy;Cancer Immunology and Immunotherapy;2022